HC Wainwright Initiates Coverage on Avalo Therapeutics (NASDAQ:AVTX)
HC Wainwright began coverage on shares of Avalo Therapeutics (NASDAQ:AVTX – Free Report) in a report released on Monday morning, MarketBeat Ratings reports. The firm issued a buy rating and a $15.00 price target on the stock. AVTX has been the topic of several other reports. Stifel Nicolaus initiated coverage on Avalo Therapeutics in a […]
